Aridis Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep '23 Sep 30, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Cash & Equivalents	0.04	4.88	18.1	8.23	20.9	24.24
Cash & Short-Term Investments	0.04	4.88	18.1	8.23	20.9	24.24
Cash Growth	-98.14%	-73.06%	119.85%	-60.61%	-13.78%	-3.42%
Accounts Receivable	0.42	1	-	-	-	1.66
Other Receivables	0.1	0.24	0.24	0.37	0.41	0.44
Receivables	0.52	1.24	0.24	0.37	0.41	2.1
Prepaid Expenses	3.56	3.34	2.7	2.18	2.99	1.56
Restricted Cash	-	0.18	1.39	-	-	-
Other Current Assets	-	1.99	1.97	1.97	1.54	0.46
Total Current Assets	4.11	11.63	24.39	12.76	25.84	28.35
Property, Plant & Equipment	1.58	2.15	1.36	1.26	1.01	1.27
Long-Term Investments	-	-	-	-	0.01	0.96
Other Intangible Assets	0.01	0.02	0.02	0.03	0.03	0.04
Long-Term Deferred Charges	-	0.08	0.1	0.09	0.53	-
Other Long-Term Assets	0.83	0.83	0.93	0.99	0.56	1
Total Assets	6.53	14.7	26.8	15.12	27.97	31.61
Accounts Payable	5.41	2.31	5.24	1.89	1.76	2.33
Accrued Expenses	7.69	9.56	6.46	1.33	2.97	2.94
Short-Term Debt	-	0.52	0.7	-	-	-
Current Portion of Long-Term Debt	3.41	3.78	-	0.44	-	-
Current Portion of Leases	0.58	0.54	-	-	-	-
Current Unearned Revenue	0.38	20.17	20.84	18.75	14.6	0.02
Other Current Liabilities	0.02	0.02	0.11	0.04	-	-
Total Current Liabilities	17.48	36.9	33.35	22.44	19.33	5.3
Long-Term Debt	-	-	5.28	0.28	-	-
Long-Term Leases	0.85	1.29	-	-	-	-
Long-Term Unearned Revenue	-	0.74	0.91	0.85	5	-
Other Long-Term Liabilities	-	-	0.36	0.23	-	-
Total Liabilities	18.34	38.93	39.91	23.8	24.33	5.3
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	170.83	166.38	152.18	114.42	104.4	97.4
Retained Earnings	-190.42	-195.67	-165.3	-123.1	-100.77	-71.09
Comprehensive Income & Other	7.79	5.05	-	-	-	-
Total Common Equity	-11.8	-24.23	-13.11	-8.68	3.64	26.31
Shareholders' Equity	-11.8	-24.23	-13.11	-8.68	3.64	26.31
Total Liabilities & Equity	6.53	14.7	26.8	15.12	27.97	31.61
Total Debt	4.84	6.13	5.98	0.72	-	-
Net Cash (Debt)	-4.81	-1.25	12.12	7.52	20.9	24.24
Net Cash Growth	-	-	61.23%	-64.03%	-13.78%	-3.42%
Net Cash Per Share	-0.15	-0.07	0.99	0.82	2.47	7.70
Filing Date Shares Outstanding	44.57	36.08	17.7	11.23	8.92	8.11
Total Common Shares Outstanding	44.57	27.03	17.7	10.07	8.92	8.1
Working Capital	-13.37	-25.27	-8.96	-9.69	6.51	23.05
Book Value Per Share	-0.26	-0.90	-0.74	-0.86	0.41	3.25
Tangible Book Value	-11.82	-24.25	-13.13	-8.71	3.6	26.28
Tangible Book Value Per Share	-0.27	-0.90	-0.74	-0.87	0.40	3.24
Machinery	2.23	2.25	2.42	2.23	1.83	1.76
Construction In Progress	-	-	-	0.19	-	-
Leasehold Improvements	0.53	0.53	0.53	-	-	-

Updated Nov 6, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.